Gb Sciences Stock EBITDA
GBLX Stock | USD 0.01 0 33.00% |
GB Sciences fundamentals help investors to digest information that contributes to GB Sciences' financial success or failures. It also enables traders to predict the movement of GBLX Pink Sheet. The fundamental analysis module provides a way to measure GB Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GB Sciences pink sheet.
GBLX |
GBLX EBITDA Analysis
GB Sciences' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current GB Sciences EBITDA | 398.73 K |
Most of GB Sciences' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GB Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
According to the company disclosure, GB Sciences reported earnings before interest,tax, depreciation and amortization of 398.73 K. This is 99.95% lower than that of the Healthcare sector and 99.6% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 99.99% higher than that of the company.
GBLX EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GB Sciences' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GB Sciences could also be used in its relative valuation, which is a method of valuing GB Sciences by comparing valuation metrics of similar companies.GB Sciences is currently under evaluation in ebitda category among related companies.
GBLX Fundamentals
Return On Equity | -50.98 | |||
Return On Asset | -0.21 | |||
Current Valuation | 10.19 M | |||
Shares Outstanding | 379.21 M | |||
Shares Owned By Insiders | 13.08 % | |||
Price To Earning | 4.04 X | |||
Price To Book | 1.08 X | |||
Price To Sales | 1.91 X | |||
Gross Profit | (881.46 K) | |||
EBITDA | 398.73 K | |||
Net Income | (530.87 K) | |||
Cash And Equivalents | 53.96 K | |||
Total Debt | 397.31 K | |||
Debt To Equity | 1.07 % | |||
Current Ratio | 0.03 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (1.87 M) | |||
Beta | 0.56 | |||
Market Capitalization | 8.21 M | |||
Total Asset | 2.55 M | |||
Retained Earnings | (78.28 M) | |||
Working Capital | 881 K | |||
Current Asset | 2.2 M | |||
Current Liabilities | 1.32 M | |||
Z Score | -30.0 | |||
Net Asset | 2.55 M |
About GB Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GB Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GB Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GB Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out GB Sciences Piotroski F Score and GB Sciences Altman Z Score analysis. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for GBLX Pink Sheet analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |